Ethyl 2-[(6-bromo-2-oxo-2H-chromen-3-yl)formamido]acetate

Catalog No.: 
ACOWML283
CAS No.: 
866155-17-1
Molecular Formula: 
C14H12BrNO5
Molecular Weight: 
354.16
Ethyl 2-[(6-bromo-2-oxo-2H-chromen-3-yl)formamido]acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$104.00InquiryInquiry
1g90%$324.00InquiryInquiry
5g90%$1604.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-[(6-bromo-2-oxo-2H-chromen-3-yl)formamido]acetate
IUPAC Nameethyl (6-bromo-2-oxo-2H-chromene-3-carbonyl)glycinate
Molecular FormulaC14H12BrNO5
Molecular Weight354.16
SMILESO=C(OCC)CNC(C(C1=O)=CC2=C(O1)C=CC(Br)=C2)=O
InChI KeyKCSRVCTUSYOSEE-UHFFFAOYSA-N
Synonymethyl 2-[(6-bromo-2-oxo-2H-chromen-3-yl)formamido]acetate;Glycine, N-[(6-bromo-2-oxo-2H-1-benzopyran-3-yl)carbonyl]-, ethyl ester
CAS No.866155-17-1

Synthetic Route by SureRoute

1. ACOWML283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6In Stock
  2. Plus
  3. ACNMVP780 route compound structure diagram
    ACNMVP7802199-87-3In Stock
  4. Then
  5. ACOWML283 route product structure diagram
    ACOWML283866155-17-1
Inquiry

2. ACOWML283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6In Stock
  2. Plus
  3. ACOUML912 route compound structure diagram
    ACOUML9122199-90-8In Stock
  4. Then
  5. ACOWML283 route product structure diagram
    ACOWML283866155-17-1
Inquiry

3. ACOWML283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOWML283 route product structure diagram
    ACOWML283866155-17-1
Inquiry

Comments (0)